PACIRA BIOSCIENCES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
PACIRA BIOSCIENCES, INC. (PCRX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.32 million for the 6-month period ending 2011-06-30, per its 10-Q filed 2011-08-11.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2011-08-11
- 2011-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month $1.32M.
- 2010-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month $5.28M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 6 month |
|---|---|
| 2011-06-30 | $1.32M 10-Q · filed 2011-08-11 |
| 2010-06-30 | $5.28M 10-Q · filed 2011-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |